Educational Programs for You and Your Staff

Get the latest news on canine inappetence and ENTYCE® (capromorelin oral solution), the only FDA-approved veterinary therapeutic for stimulating appetite in dogs.

Webinars

Join an upcoming live webinar from the convenience of your home or office. These online sessions are provided at no cost to you as an educational service by Aratana Therapeutics.

 

November 13

A New Chapter in the Treatment of Inappetence 
1-hour RACE CE webinar*

November 13, 2018
1:00 p.m. ET / 12:00 p.m. CT / 11 a.m. MT / 10 a.m. PT

Presented by Natalie Marks, DVM, CVJ

Dr. Natalie Marks obtained her bachelor’s degree with High Honors in Animal Science from the University of Illinois in 1998, followed by her Masters in Veterinary Medicine and Doctorate of Veterinary Medicine with High Honors from the University of Illinois College of Veterinary Medicine. She became a Certified Veterinary Journalist in 2018.

Dr. Marks has been a veterinarian at Blum Animal Hospital since 2006 and Medical Director since 2012. Prior to 2006, she worked at a small animal practice outside Atlanta, GA. Since her return to Chicago, Dr. Marks has been active in the Chicago Veterinary Medical Association, serving on the executive board. She is also a past board member of the Illinois State Veterinary Medical Association and active with the American Veterinary Medical Association and American Animal Hospital Association. Her numerous awards include Petplan’s nationally-recognized 2012 Veterinarian of the Year, America’s Favorite Veterinarian for 2015 by the American Veterinary Medical Foundation and, most recently, Nobivac’s 2017 Veterinarian of the Year for her work on canine influenza.

Dr. Marks is a frequent contributor to Fox News. She has also appeared on Good Day Chicago, WGN-Pet Central, NBC Morning News, ABC, CBS, NPR, WBBM, Northwestern University media channel and been published in local and national publications. Finally, Dr. Marks sits on the Fear Free national advisory board and is a national educator helping other private practitioners develop these techniques.

*This program has been approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval.

IMPORTANT SAFETY INFORMATION: ENTYCE® (capromorelin oral solution) is for use in dogs only. Do not use in breeding, pregnant or lactating dogs. Use with caution in dogs with hepatic dysfunction or renal insufficiency. Adverse reactions in dogs may include diarrhea, vomiting, polydipsia, and hypersalivation. Should not be used in dogs that have a hypersensitivity to capromorelin. Please see the full Prescribing Information for more detail.

Other therapeutics from Aratana

Nocita® (bupivacaine liposome injectable suspension)
NOCITA® (bupivacaine liposome injectable suspension) is the only long-acting local anesthetic that controls post-op pain with one dose at the source for up to 72 hours following canine cranial cruciate ligament surgery or feline onychectomy to help patients recover comfortably. 

Visit Website >

DOG INDICATION: For single-dose infiltration into the surgical site to provide local post-operative analgesia for cranial cruciate ligament surgery in dogs.

IMPORTANT SAFETY INFORMATION: NOCITA® (bupivacaine liposome injectable suspension) is for local infiltration injection in dogs only. Do not use in dogs younger than 5 months of age, that are pregnant, lactating or intended for breeding. Do not administer by intravenous or intra-arterial injection. Adverse reactions in dogs may include discharge from incision, incisional inflammation and vomiting. Avoid concurrent use with bupivacaine HCl, lidocaine or other amide local anesthetics. Please see the full Prescribing Information for more detail.

CAT INDICATION: For use as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats.

IMPORTANT SAFETY INFORMATION: NOCITA® (bupivacaine liposome injectable suspension) is for use as a peripheral nerve block in cats only. Do not use in cats younger than 5 months of age, that are pregnant, lactating, or intended for breeding. Do not administer by intravenous or intra-arterial injection. Adverse reactions in cats may include elevated body temperature, infection or chewing/licking at the surgical site. Avoid concurrent use with bupivacaine HCl, lidocaine or other amide local anesthetics. Please see the full Prescribing Information for more detail.